ProgressImage ProgressImage
Bharat Immunological & Biological Corporation Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 524663 border-img ISIN Demat INE994B01014 border-img Book Value -7.54 border-img NSE Symbol N.A border-img Div & Yield % 0 border-img Market Cap (₹ Cr.) 39.64 border-img P/E 0 border-img EPS 0 border-img Face Value 10
Mar 2023
(₹ Cr.)
Mar 2022
(₹ Cr.)
Mar 2021
(₹ Cr.)
Mar 2020
(₹ Cr.)
Mar 2019
(₹ Cr.)
Mar 2018
(₹ Cr.)
SOURCES OF FUNDS :       
Share Capital 43.1843.1843.1843.1843.1843.18
Reserves Total 44.6262.17-9.14-22.71-12.50-5.69
Equity Share Warrants 0.000.000.000.000.000.00
Equity Application Money 0.000.000.000.000.000.00
Total Shareholders Funds 87.80105.3534.0420.4730.6837.49
Secured Loans 0.000.000.000.000.000.00
Unsecured Loans 70.2277.8927.293.0432.220.00
Total Debt 70.2277.8927.293.0432.220.00
Other Liabilities 6.426.115.855.655.813.38
Total Liabilities 164.44189.3567.1829.1668.7140.87
APPLICATION OF FUNDS :       
Gross Block 157.12157.6245.664.475.975.94
Less : Accumulated Depreciation 41.7941.6441.430.001.270.99
Less:Impairment of Assets 0.000.000.000.000.000.00
Net Block 115.33115.984.234.474.704.95
Lease Adjustment 0.000.000.000.000.000.00
Capital Work in Progress 0.000.0031.900.220.220.22
Producing Properties 0.000.000.000.000.000.00
Investments 0.000.000.000.000.000.00
Current Assets, Loans & Advances       
Inventories 1.4336.2513.4951.7214.441.72
Sundry Debtors 13.881.130.0117.6172.9715.94
Cash and Bank Balance 8.7413.0110.5412.107.9320.00
Loans and Advances 9.0215.039.9211.593.390.53
Total Current Assets 33.0665.4333.9593.0298.7338.20
Less : Current Liabilities and Provisions       
Current Liabilities 14.2118.0332.3796.7955.4511.79
Provisions 7.025.354.420.880.800.73
Total Current Liabilities & Provisions 21.2223.3836.7997.6756.2512.52
Net Current Assets 11.8442.05-2.84-4.6542.4825.68
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets 26.8221.0320.3614.2314.618.16
Deferred Tax Liability 0.000.000.270.234.600.23
Net Deferred Tax 26.8221.0320.0914.0010.017.93
Other Assets 10.4410.2913.8115.1311.302.10
Total Assets 164.43189.3567.1929.1668.7140.88
Contingent Liabilities 0.000.000.000.000.003.96
`

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.   Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day...... issued in the interest of investors.    KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.      No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment.No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account   |    Website Accessibility Statement   |    CDSL MyEasi   |    TRAI Notice on UCC   |    SEBI Risk Disclosure   |    Investor Notice

Disclaimer : Investment in securities market are subject to market risks, read all the related documents carefully before investing. Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

x
x
×
Let's Chat
imsl-img
close
refresh